<table frame="hsides" xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><caption>Table 7: Erosive Esophagitis Patient Healing Rates</caption>
<thead>
<tr><td align="center" valign="top"></td><td align="center" colspan="2" valign="top">Healed/Evaluable</td></tr>
<tr><td align="center" valign="top"></td><td align="center" valign="top"></td><td align="center" valign="top">Ranitidine</td></tr>
<tr><td align="center" valign="top"></td><td align="center" valign="top">Placebo<sup>*</sup></td><td align="center" valign="top">150 mg q.i.d.<sup>*</sup></td></tr>
<tr><td align="center" valign="top"></td><td align="center" valign="top">n=229</td><td align="center" valign="top">n=215</td></tr>
</thead>
<tfoot>
<tr><td colspan="3" valign="top"><sup>*</sup>All patients were permitted p.r.n antacids for relief of pain.</td></tr>
<tr><td colspan="3" valign="top">†<content stylecode="italics">P </content>&lt;0.001 versus placebo.</td></tr>
</tfoot>
<tbody>
<tr><td valign="top">Week 4</td><td align="center" valign="top">43/198 (22%)</td><td align="center" valign="top">96/206 (47%)<sup>†</sup></td></tr>
<tr><td valign="top">Week 8</td><td align="center" valign="top">63/176 (36%)</td><td align="center" valign="top">142/200 (71%)<sup>†</sup></td></tr>
<tr><td valign="top">Week 12</td><td align="center" valign="top">92/159 (58%)</td><td align="center" valign="top">162/192 (84%)<sup>†</sup></td></tr>
</tbody>
</table>